Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432K Sell
4,531
-117
-3% -$11.2K 0.02% 726
2026
Q1
$482K Buy
4,648
+2,283
+97% +$259K 0.02% 580
2025
Q4
$238K Sell
2,365
-587
-20% -$63.7K 0.01% 909
2025
Q3
$364K Buy
2,952
+289
+11% +$35.9K 0.02% 625
2025
Q2
$320K Buy
2,663
+292
+12% +$39K 0.02% 649
2025
Q1
$349K Sell
2,371
-744
-24% -$114K 0.03% 532
2024
Q4
$506K Buy
3,115
+1,320
+74% +$216K 0.04% 358
2024
Q3
$292K Buy
1,795
+694
+63% +$103K 0.03% 470
2024
Q2
$150K Buy
1,101
+149
+16% +$20.7K 0.02% 596
2024
Q1
$146K Buy
952
+130
+16% +$19.4K 0.03% 494
2023
Q4
$119K Buy
+822
New +$110K 0.03% 473

Other funds holding CLX

GAMMA Investing's CLX Position: Q2 2026 in Review

GAMMA Investing reduced its Clorox (CLX) stake by 2.5% in Q2 2026, selling an estimated $11.2K and leaving 4,531 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #726.

GAMMA Investing first reported a position in CLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $506K in Q4 2024. 218 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • GAMMA Investing held 4,531 shares of Clorox worth $432K as of Q2 2026.
  • GAMMA Investing sold 117 Clorox shares in Q2 2026, an estimated $11.2K.
  • Clorox made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #726 holding.
  • GAMMA Investing first reported a position in Clorox in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Clorox position peaked at $506K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.